AbstractIntroductionRecent studies have shown that pathologically defined subtypes of Alzheimer's disease (AD) represent distinctive atrophy patterns and clinical characteristics. We investigated whether a cortical thickness–based clustering method can reflect such findings.MethodsA total of 77 AD subjects from the Alzheimer's Disease Neuroimaging Initiative 2 data set who underwent 3-T magnetic resonance imaging, [18F]-fluorodeoxyglucose-positron emission tomography (PET), [18F]-Florbetapir PET, and cerebrospinal fluid (CSF) tests were enrolled. After clustering based on cortical thickness, diverse imaging and biofluid biomarkers were compared between these groups.ResultsThree cortical thinning patterns were noted: medial temporal (MT; 19....
AbstractMild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia are preceded by a phas...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
MRI studies have consistently identified atrophy patterns in Alzheimer’s disease (AD) through a whol...
Introduction: Recent studies have shown that pathologically defined subtypes of Alzheimer's dise...
AbstractIntroductionRecent studies have shown that pathologically defined subtypes of Alzheimer's di...
International audiencePredicting Alzheimer's disease (AD) in individuals with some symp-toms of cogn...
Alzheimer's disease (AD) is associated with neurodegeneration in vulnerable limbic and heteromodal r...
Objective: Because the signs associated with dementia due to Alzheimer disease (AD) can be heterogen...
Objective: To assess patterns of reduced cortical thickness in different clinically defined variants...
OBJECTIVE: Because the signs associated with dementia due to Alzheimer disease (AD) can be heterogen...
International audiencePredicting Alzheimer's disease (AD) in individuals with some symptoms of cogni...
Predicting Alzheimer's disease (AD) in individuals with some symptoms of cognitive decline may have ...
Defining a signature of cortical regions of interest preferentially affected by Alzheimer disease (A...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
The biological mechanisms that link Beta-amyloid (Aβ) plaque deposition, neurodegeneration, and clin...
AbstractMild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia are preceded by a phas...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
MRI studies have consistently identified atrophy patterns in Alzheimer’s disease (AD) through a whol...
Introduction: Recent studies have shown that pathologically defined subtypes of Alzheimer's dise...
AbstractIntroductionRecent studies have shown that pathologically defined subtypes of Alzheimer's di...
International audiencePredicting Alzheimer's disease (AD) in individuals with some symp-toms of cogn...
Alzheimer's disease (AD) is associated with neurodegeneration in vulnerable limbic and heteromodal r...
Objective: Because the signs associated with dementia due to Alzheimer disease (AD) can be heterogen...
Objective: To assess patterns of reduced cortical thickness in different clinically defined variants...
OBJECTIVE: Because the signs associated with dementia due to Alzheimer disease (AD) can be heterogen...
International audiencePredicting Alzheimer's disease (AD) in individuals with some symptoms of cogni...
Predicting Alzheimer's disease (AD) in individuals with some symptoms of cognitive decline may have ...
Defining a signature of cortical regions of interest preferentially affected by Alzheimer disease (A...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
The biological mechanisms that link Beta-amyloid (Aβ) plaque deposition, neurodegeneration, and clin...
AbstractMild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia are preceded by a phas...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
MRI studies have consistently identified atrophy patterns in Alzheimer’s disease (AD) through a whol...